Scarica l'app Stockscreener
0.6152
0.84%
0.0051
Dopo l'orario di chiusura:
1.96
1.3448
+218.60%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.6101
Aprire:
$0.607
Volume 24 ore:
145.79K
Relative Volume:
0.52
Capitalizzazione di mercato:
$29.64M
Reddito:
$2.82M
Utile/perdita netta:
$-13.47M
Rapporto P/E:
-0.9047
EPS:
-0.68
Flusso di cassa netto:
$-13.61M
1 W Prestazione:
-1.65%
1M Prestazione:
+43.04%
6M Prestazione:
-32.39%
1 anno Prestazione:
-46.97%
Intervallo 1D:
$0.607
$0.6498
Intervallo di 1 settimana:
$0.601
$0.7349
Portata 52W:
$0.3954
$1.39
Neuroone Medical Technologies Corp Stock (NMTC) Company Profile
Nome
Neuroone Medical Technologies Corp
Settore
Industria
Telefono
(952) 426-1383
Indirizzo
7599 ANAGRAM DR, EDEN PRAIRIE
Confronta NMTC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| 0.99 | 0 | 0 | 0 | 0 | 0.00 | |
GOODO
Gladstone Commercial Corporation
|
20.37 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1612 | 337.87M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
MOBBW
Mobilicom Limited Warrants
|
0.28 | 291.74M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
10.95 | 226.20M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
3.46 | 172.25M | 0 | 0 | 0 | 0.00 |
Neuroone Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-05 | Iniziato | Ladenburg Thalmann | Buy |
| 2022-03-29 | Downgrade | Craig Hallum | Buy → Hold |
Neuroone Medical Technologies Corp Borsa (NMTC) Ultime notizie
NeuroOne Medical Opens Exclusive Investor Access: CFO Hosts One-on-One Meetings at Plaza Hotel - Stock Titan
NeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global Conference - The Kingston Whig Standard
NeuroOne Medical Tech (NMTC) Coverage Initiated by Ladenburg Tha - GuruFocus
This Okta Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Geode Capital Management LLC Grows Stake in NeuroOne Medical Technologies Co. (NASDAQ:NMTC) - Defense World
NeuroOne Earnings: Medical Tech Leader to Reveal Q2 2025 Growth Strategy and Financial Results - Stock Titan
NeuroOne Medical Technologies Corp [NMTC] Records 50-Day SMA of $0.8911 - knoxdaily.com
NeuroOne Medical Technologies Corp’s results are impressive - uspostnews.com
The Future of NeuroOne Medical Technologies Corp: Analyzing NMTC - investchronicle.com
NeuroOne Medical (NMTC) Files Early FDA Submission for Trigemina - GuruFocus
NeuroOne Medical (NMTC) Files Early FDA Submission for Trigeminal Nerve Ablation | NMTC Stock News - GuruFocus
NeuroOne files early FDA 510(k) for nerve ablation system - Investing.com
NeuroOne's Revolutionary Facial Pain Treatment Advances: FDA Review Next for 95% Effective Device - Stock Titan
EXCLUSIVE: NeuroOne Submits FDA Marketing Application For OneRF Trigeminal Nerve Ablation System For Facial Pain - Benzinga
NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call Highlights: Regulatory Success ... - Yahoo Finance
NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call - GuruFocus
CTEK Expects Significant Revenue Growth by Fiscal Year 2025 | NMTC Stock News - GuruFocus
NeuroOne Medical (NMTC) Expands Partnership with Zimmer Biomet and Secures Funding | NMTC Stock News - GuruFocus
Neuroone Medical Technologies Corp -Company Now Fully Funded Through At Least Fiscal 2026 - marketscreener.com
NeuroOne secures funding through fiscal 2026, unaffected by tariffs - Investing.com
NeuroOne Secures $11.3M in Fresh Capital, Forecasts Triple-Digit Growth - Stock Titan
NeuroOne Medical (NMTC) Gains Attention with Successful Pediatric Epilepsy Treatment | NMTC Stock News - GuruFocus
Breakthrough: Teen Goes from 10 Seizures Per Night to Zero with New Brain Treatment - Stock Titan
Teen goes from 10 nightly seizures to zero with brain implant - Fox News
Ronald McClurg Spends US$100k On NeuroOne Medical Technologies Stock - Yahoo
NeuroOne Medical Technologies CEO buys $50,000 in common stock By Investing.com - Investing.com India
NeuroOne Medical Technologies CEO buys $50,000 in common stock - Investing.com Australia
NeuroOne Medical’s CFO Ronald McClurg buys $100,000 in stock By Investing.com - Investing.com South Africa
NeuroOne Medical's CFO Ronald McClurg buys $100,000 in stock - Investing.com
NeuroOne Executives Make Significant Stock Purchases - TradingView
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Nasdaq Dips 5%; NeuroOne Medical Technologies Shares Plummet - Benzinga
NeuroOne Announces Proposed Public Offering Of Common Stock To Raise Capital For Growth - Nasdaq
Neuroone stock hits 52-week low at $0.48 amid market challenges By Investing.com - Investing.com South Africa
Neuroone stock hits 52-week low at $0.48 amid market challenges - Investing.com
NeuroOne (NMTC) Announces $8 Million Public Offering - GuruFocus
Dow Tumbles 1,100 Points; US Economy Adds 228,000 Jobs In March - Benzinga
NeuroOne Medical Technologies prices $8 million public offering of common stock - MSN
NeuroOne sets price for 16 million share offering - Investing.com
NeuroOne Raises $8M: Inside the Major Public Offering That's Catching Investor Attention - Stock Titan
Guess, Simulations Plus And 3 Stocks To Watch Heading Into Friday - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
NeuroOne announces public offering of common stock - Investing.com
NeuroOne Medical Announces Strategic Stock Offering with Ladenburg Thalmann - Stock Titan
Fostering clinician-led biotech innovation - Medical Economics
Game-Changing Epilepsy Innovation: NeuroOne's FDA-Cleared Device Transforms Brain Treatment - StockTitan
NeuroOne CEO Joins Today's Marketplace To Discuss The Latest Treatments for Epilepsy - Quantisnow
Breakthrough: First-Ever FDA-Cleared Device Transforms Epilepsy Treatment for 50M Patients - StockTitan
Tariffs and medical devices: What has the industry response been? - Medical Economics
NeuroOne Targets May 2025 FDA Submission For OneRF Trigeminal Nerve Ablation System - Nasdaq
NeuroOne accelerates FDA submission timeline for nerve ablation tech - Mass Device
Neuroone Medical Technologies Corp Azioni (NMTC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.11%
0.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):